Skip to main content

US BANCORP \DE\

Bank

Position in KROS — Keros Therapeutics, Inc.

CIK 36104 MINNEAPOLIS, MN

Position in KROS

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$107
-$279 QoQ
Shares Held
10
-71.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#127
of 131 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KROS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

US BANCORP \DE\ holds $82,066,335 across 213 Biotechnology names. KROS ranks #205 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KROS

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $107 10
2026-03-31 $386 35
2025-12-31 $10,872 534
2025-09-30 $8,447 534
2025-06-30 $131,684 9,864
2025-03-31 $163 16
2024-12-31 $3,007 190
2024-09-30 $14,343 247
2024-06-30 $13,024 285
2024-03-31 $26,149 395
2023-12-31 $13,796 347
2023-06-30 $2,209 55
2023-03-31 $2,348 55
2022-12-31 $2,641 55
2022-09-30 $2,069 55
2022-06-30 $1,132 41
2022-03-31 $2,229 41
2021-12-31 $2,398 41
2021-09-30 $1,621 41